advanc
molecular
biolog
bioinformat
robot
allow
microarray
technolog
use
indepth
basic
scienc
studi
field
microbiolog
recent
translat
basic
scienc
applic
clinic
microbiolog
infecti
diseas
also
progress
clinic
infecti
diseas
perspect
genomebas
organ
identif
pathogen
discoveri
antimicrobi
suscept
test
problemat
organ
offer
potenti
yield
diagnost
inform
may
otherwis
becom
avail
moreov
microarraybas
studi
abil
provid
signatur
host
cell
transcript
respons
individu
pathogen
andor
group
pathogen
type
inform
potenti
confirm
difficult
diagnos
monitor
respons
therapeut
intervent
even
predict
prognosi
sequela
follow
infecti
diseas
exampl
present
illustr
way
microarray
technolog
alreadi
impact
area
clinic
microbiolog
microbiolog
newslett
see
frontmatt
past
decad
move
time
entir
research
paper
base
sequenc
singl
gene
singl
bacteri
operon
singl
manuscript
describ
entir
genom
avail
level
genet
inform
spawn
term
function
genom
transcriptom
proteom
even
metabonom
field
studi
describ
largescal
applic
global
gene
express
profil
protein
analysi
metabolit
analysi
case
power
bioinformat
tool
link
comprehens
databas
essenti
drive
process
review
focus
role
gene
express
profil
begun
play
clinic
microbiolog
discuss
potenti
pathogen
identif
pathogen
discoveri
novel
therapeut
discoveri
avail
complet
microbi
genom
continu
grow
rapidli
differ
complet
pathogen
genom
date
becam
avail
list
tabl
link
complet
microbi
genom
partial
sequenc
ongo
pathogenrel
genom
project
avail
web
site
institut
genom
research
http
wwwtigrorg
explos
avail
microbi
genom
sequenc
data
molecular
biolog
approach
gene
express
studi
advanc
quickli
differenti
display
gene
macroarray
serial
analysi
gene
express
provid
great
insight
diseas
pathogenesi
microarray
power
high
throughput
potenti
sever
exampl
technolog
appli
address
translat
research
question
present
excel
comprehens
review
discuss
advantag
nuanc
technolog
hurdl
involv
use
techniqu
context
clinic
microbiolog
differenti
display
first
describ
laborintens
semiquantit
revers
transcriptas
pcr
rtpcr
base
techniqu
use
compar
mrna
deriv
differ
experiment
condit
total
rna
extract
control
experiment
condit
interest
arbitrari
primer
pair
use
rtpcrbase
reaction
condit
gener
differenti
display
signal
intens
seen
side
side
signal
interest
amplicon
band
appear
induc
upregul
cut
gel
elut
reamplifi
confirm
differenti
express
amplicon
label
use
probe
northern
blot
confirm
amplicon
sequenc
sound
ineffici
given
today
technolog
offer
uniqu
potenti
novel
gene
discoveri
fact
van
den
hoogen
et
al
identifi
first
human
metapneumoviru
genet
sequenc
use
technolog
studi
rna
extract
cell
appear
exhibit
respiratori
syncyti
viruslik
cytopath
effect
could
confirm
contain
previous
known
human
viru
human
metapneumoviru
wellrecogn
caus
acut
respiratori
tract
infect
laborintens
technolog
differenti
display
quickli
join
effici
gene
macroarray
technolog
macroarray
membran
imprint
hundr
cdna
probe
usual
consist
themat
element
gene
associ
inflamm
techniqu
use
familiar
number
gene
evalu
target
somewhat
limit
analysi
interpret
macroarray
result
accomplish
use
standard
protocol
techniqu
offer
potenti
novel
gene
discoveri
probe
includ
membran
known
sequenc
concept
deposit
multipl
dna
spot
repres
differ
gene
onto
membran
surfac
new
especi
microbiolog
year
ago
chuang
et
al
investig
escherichia
coli
gene
express
macroarray
membran
commerci
macroarray
becom
wide
avail
sinc
report
giant
leap
forward
assess
transcript
genom
scale
realiz
develop
avail
dna
microarray
array
glass
slide
chip
contain
order
mosaic
entir
genom
collect
either
oligonucleotid
oligonucleotid
microarray
cdna
repres
individu
gene
cdna
microarray
classic
northern
southern
blot
approach
detect
specif
dna
mrna
speci
provid
technic
basi
microarray
hybrid
fluoresc
label
cdna
applic
robot
achiev
high
spot
densiti
glass
slide
facilit
construct
microarray
contain
gene
singl
slide
chip
like
differenti
display
process
obtain
gene
express
data
use
microarray
techniqu
start
rna
extract
biolog
condit
interest
vitro
transcript
reaction
allow
incorpor
biotinyl
nucleotid
label
transcript
pool
transcript
fragment
heat
hybrid
microarray
gene
chip
array
wash
stain
scan
databas
scan
imag
compar
replic
data
gener
sampl
sampl
deriv
differ
experiment
condit
interest
follow
rigor
valid
statist
algorithm
appli
determin
gene
express
normal
express
data
per
gene
andor
per
chip
allow
rel
gene
express
intens
compar
across
differ
experiment
condit
data
reduct
softwar
bioinformat
databas
lend
enorm
power
kind
comparison
critic
skeptic
microarray
technolog
argu
genom
scale
research
larg
nonhypothesisdriven
scienc
howev
advoc
view
technolog
posit
alreadi
reveal
function
gene
may
miss
convent
approach
like
continu
need
genomewid
approach
gene
express
experi
becom
appar
one
consid
genom
sequenc
e
coli
hand
year
microb
still
contain
gene
unknown
function
role
gene
discov
without
applic
function
genom
technolog
combin
creativ
experi
function
genom
allow
research
make
new
unexpect
link
function
unrel
hitherto
uncharacter
gene
put
forth
hypothes
subsequ
test
tradit
method
clinic
potenti
microarray
technolog
enorm
global
transcript
analys
use
identifi
pathogen
discov
new
pathogen
predict
antimicrobi
suscept
determin
host
gene
express
signatur
attempt
defin
marker
diseas
sever
andor
prognosi
indepth
review
applic
well
beyond
scope
perspect
exampl
technolog
appli
area
offer
microarray
technolog
appli
pathogen
identif
pioneer
studi
behr
colleagu
use
microarray
technolog
genet
character
differ
variant
mycobacterium
bovi
bacillu
bcg
strain
part
mycobacterium
tuberculosi
complex
purpos
gener
pcrbase
array
repres
open
read
frame
tuberculosi
array
use
framework
genom
analysi
bcg
strain
hybrid
label
genom
dna
studi
document
region
delet
bcg
strain
compar
tuberculosi
strain
rang
base
almost
base
particular
interest
nine
region
repres
open
read
frame
present
tuberculosi
consist
absent
bovi
strain
includ
bcg
author
provid
hypothesi
lack
cluster
phospholipas
c
gene
bovi
genom
might
respons
decreas
abil
organ
spread
person
person
compar
tuberculosi
discoveri
obviou
implic
microbi
pathogenesi
virul
relat
pathogen
identif
collect
open
read
frame
absent
bovi
isol
like
prove
valuabl
diagnost
peopl
infect
tuberculosi
could
theoret
distinguish
peopl
vaccin
bcg
exactli
type
clinic
situat
specif
direct
reliabl
pathogen
identif
could
influenc
longterm
therapeut
decis
oligonucleotid
microarray
alreadi
shown
use
discoveri
novel
agent
obviou
advantag
includ
possibl
detect
caus
epidem
caus
biolog
terror
event
techniqu
paper
publish
fall
describ
methodolog
immedi
appli
identif
agent
sever
acut
respiratori
syndrom
sar
sever
month
later
techniqu
use
evalu
patient
sar
although
electron
microscopi
show
presenc
viru
rna
infect
cell
hybrid
oligonucleotid
microarray
j
dirisi
show
agent
genet
signatur
consist
novel
coronaviru
panviru
microarray
consist
posit
signal
seven
loci
identifi
four
match
similar
probe
loop
stem
two
differ
astrovirus
ovin
astroviru
avian
nephriti
viru
two
coronavirus
avian
infecti
bronchiti
viru
bovin
coronaviru
also
three
posit
signal
identifi
relat
polymeras
three
differ
coronavirus
includ
avian
bovin
human
coronaviru
taken
togeth
find
electron
microscopi
result
immedi
identifi
like
sar
agent
novel
human
coronaviru
within
sever
week
caus
agent
sar
known
least
complet
sar
coronaviru
sequenc
avail
genbank
koch
postul
fulfil
fouchier
et
al
infect
primat
newli
discov
viru
develop
respiratori
ill
respons
viru
inoculum
treatment
prevent
experi
way
rapid
result
use
microarray
approach
potenti
simplifi
facilit
suscept
test
particularli
troublesom
pathogen
diagnost
microarray
explor
plasmidand
transposonmedi
resist
staphylococcu
aureu
e
coli
salmonella
spp
use
test
quinolon
resist
neisseria
gonorrhoea
multidrug
resist
tuberculosi
also
use
identifi
suscept
profil
antiretrovir
drug
use
human
immunodefici
viru
antifung
test
also
explor
detail
includ
effect
antifung
agent
gene
express
candida
albican
interest
twist
straightforward
applic
antimicrobi
resist
test
use
microarray
wilson
et
al
use
whole
genom
array
investig
effect
antimycobacteri
drug
isoniazid
gene
express
pattern
tuberculosi
known
mechan
action
isoniazid
select
interrupt
mycol
acid
synthesi
studi
serv
model
experi
look
inhibitor
essenti
metabol
pathway
express
profil
sever
gene
encod
mycol
acid
biosynthet
enzym
upregul
follow
isoniazid
challeng
upstream
downstream
known
site
action
drug
suggest
accumul
upstream
metabolit
deplet
downstream
metabolit
serv
signal
induct
gene
express
addit
sever
gene
known
involv
mycol
acid
biosynthesi
induc
potenti
identifi
link
pathway
previous
appreci
interrel
potenti
advantag
use
host
gene
express
signatur
identifi
new
target
therapeut
intervent
determin
diagnost
marker
infect
reveal
prognost
marker
outcom
potenti
use
hostcel
express
signatur
diagnost
prognost
marker
infect
profound
first
techniqu
might
permit
earli
detect
exposur
pathogen
novel
yet
cultivat
second
variat
host
cell
signatur
could
use
infer
time
sinc
exposur
third
host
cell
respons
may
continu
even
pathogen
erad
method
could
use
evalu
infecti
diseas
sequela
final
alreadi
demonstr
microarraybas
detect
sar
coronaviru
agent
even
singl
clinic
sampl
potenti
use
diagnos
infect
novel
agent
becom
well
appreci
innat
immun
respons
pathogen
pattern
stereotyp
advent
dna
microarray
research
posit
examin
hostpathogen
relationship
systemat
much
greater
detail
possibl
previous
exampl
possibl
document
cell
tissu
organ
see
pathogen
viewpoint
gene
express
respons
tempor
featur
interact
host
pathogen
character
prognost
marker
outcom
studi
novel
therapeut
intervent
identifi
test
microarraybas
gene
express
studi
human
search
gene
differenti
express
variou
patholog
state
paradigm
appli
hostpathogen
relationship
suggest
everi
pathogen
elicit
uniqu
transcript
respons
host
part
express
uniqu
virul
factor
host
respond
seri
event
includ
secret
mediat
celltocel
interact
cascad
inflammatori
event
infect
cell
recruit
inflammatori
cell
also
undergo
chang
gene
express
signatur
characterist
offend
pathogen
measur
aggreg
gene
express
pattern
infect
cell
tissu
like
signatur
gene
express
pattern
emerg
diagnost
specif
pathogen
categori
pathogen
also
predict
prognosi
studi
tempor
pattern
gene
express
sever
pneumoviru
infect
appli
microarray
technolog
rna
extract
pneumovirusinfect
lung
tissu
use
mous
model
sever
pneumoviru
infect
identifi
proinflammatori
marker
highli
upregul
infect
virul
viru
strain
infect
less
virul
strain
one
receptorligand
pair
found
highli
upregul
macrophag
inflammatori
protein
primari
receptor
chemokin
receptor
use
inform
went
studi
impact
interrupt
pathway
pneumovirusassoci
inflamm
demonstr
absolut
requir
signal
pneumovirusassoci
inflamm
clinic
studi
infant
infect
human
pneumoviru
respiratori
syncyti
viru
confirm
direct
correl
bronchoalveolar
lavag
concentr
clinic
diseas
sever
human
futur
studi
human
determin
whether
therapeut
intervent
concept
initi
deriv
microarray
analysi
effect
treatment
pneumovirusassoci
inflammatori
lung
diseas
microarray
technolog
continu
gain
attent
import
product
basic
scienc
research
tool
studi
infecti
diseas
pathogenesi
translat
advantag
grow
field
daili
clinic
practic
becom
realiti
practic
nich
techniqu
emerg
